Study on sub-chronic toxicity of Tieu thuc Kim Linh hard capsules

Pham Thi Van Anh, Vu Thi Ngoc Thanh, Dang Thi Thu Hien

Main Article Content

Abstract

Dyslipidemia syndrome is one of the important risk factors for the formation and development of atherosclerosis. Tieu Thuc Kim Linh hard capsule is formulated according to the theoretical basis of traditional medicine in treating dyslipidemia, which includes 7 herbal medications. The study was conducted to evaluate the sub-chronic toxicity of Tieu thuc Kim Linh in Wistar rats. The study showed that rats were divided into 3 groups: control; treated with Tieu thuc Kim Linh at the daily dose of 0.42 g/kg per day and 1.26 g/kg per day, respectively, for 4 consecutive weeks. After administration, rats were sacrificed to collect samples for analyzing parameters in blood at the 2nd week and 4th week. Histopathological of the liver and kidney were only observed at the 4th week. The Tieu thuc Kim Linh at 0.42 g/kg per day and 1.26 g/kg per day had no effect on body weight development and hematopoietic functions (no change in the count of erythrocytes, leukocytes, platelets, and hemoglobin amount, the activity of AST, ALT, bilirubin, albumin, cholesterol, and blood creatinine level). No change in the functions of the liver and kidney and no change in their structures observed in rats during the experiment.

Article Details

References

1. Mohamed-Yassin MS, Baharudin N, Abdul-Razak S, et al. Global prevalence of dyslipidaemia in adult populations: a systematic review protocol. BMJ Open. 2021;11(12):e049662. doi:10.1136/bmjopen-2021-049662
2. Pham D, Hung N, Khai P, et al. Prevalence of Dyslipidemia and Associated Factors among Adults in Rural Vietnam. Systematic Reviews in Pharmacy. 2020;11:185-191. doi:10.5530/srp.2020.1.25
3. Đỗ Trung Đàm. Phương pháp xác định độc tính của thuốc. Hà Nội: Nhà xuất bản Y học; 2014.
4. Mishra A, Mishra P, Tekade M, et al. Chapter 2 - Toxicology in drug research. In: Tekade R, ed. Essentials of Pharmatoxicology in Drug Research. Vol 1. Advances in Pharmaceutical Product Development and Research. Academic Press; 2023:29-56. doi:10.1016/B978-0-443-15840-7.00020-8
5. WHO. General guidelines for methodologies on research and evaluation of traditional medicine. 2000:28-29.
6. Nguyễn Đạt Anh, Nguyễn Thị Hương. Các xét nghiệm thường quy áp dụng trong thực hành lâm sàng. 3rd ed. Hà Nội: Nhà xuất bản Y học; 2013.
7. Ramaiah SK. Preclinical Safety Assessment: Current Gaps, Challenges, and Approaches in Identifying Translatable
Biomarkers of Drug-Induced Liver Injury. Clinics in Laboratory Medicine. 2011;31(1):161-172. doi:10.1016/j.cll.2010.10.004
8. Đỗ Tất Lợi. Những cây thuốc và vị thuốc Việt Nam. Hà Nội: Nhà xuất bản Y học. 2015
9. Viện Dược liệu. Cây thuốc và động vật làm thuốc. Nhà xuất bản Khoa học kỹ thuật; 2006.
10. Liu Z, Zhang X, Cui W, et al. Evaluation of short-term and subchronic toxicity of magnolia bark extract in rats. Regul Toxicol Pharmacol. 2007;49(3):160-171. doi:10.1016/j.yrtph.2007.06.006
11. Zhao YL, Wang JB, Zhou GD, et al. Investigations of free anthraquinones from rhubarb against alpha-zaphthylisothiocyanate-induced cholestatic liver injury in rats. Basic Clin Pharmacol Toxicol. 2009;104(6):463-469. doi:10.1111/j.1742-7843.2009.00389.x
12. Kaur G, Tirkey N, Chopra K. Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. Toxicology.
2006;226(2):152-160. doi:10.1016/j.tox.2006.06.018
13. Mahmoud AM, Ashour MB, Abdel-Moneim A, et al. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type
2 diabetic rats. Journal of Diabetes and its Complications. 2012;26(6):483-490. doi:10.1016/j.jdiacomp.2012.06.001
14. Khorasanian AS, Fateh ST, Gholami F, et al. The effects of hesperidin supplementation on cardiovascular risk factors in adults: a systematic review and dose–response meta-analysis. Frontiers in Nutrition. 2023;10. doi:10.3389/fnut.2023.1177708